A citation-based method for searching scientific literature

Carlos F Ibáñez. Cold Spring Harb Perspect Biol 2013
Times Cited: 101



M Santoro, F Carlomagno, A Romano, D P Bottaro, N A Dathan, M Grieco, A Fusco, G Vecchio, B Matoskova, M H Kraus. Science 1995
Times Cited: 705




List of shared articles



Times cited

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
4

RET receptor signaling: Function in development, metabolic disease, and cancer.
Masahide Takahashi. Proc Jpn Acad Ser B Phys Biol Sci 2022
3

RET signaling pathway and RET inhibitors in human cancer.
Angelina T Regua, Mariana Najjar, Hui-Wen Lo. Front Oncol 2022
0

RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz M Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Kalinka. Cancers (Basel) 2022
0


The importance of the RET gene in thyroid cancer and therapeutic implications.
Domenico Salvatore, Massimo Santoro, Martin Schlumberger. Nat Rev Endocrinol 2021
26

Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
3

Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.
Albana Gattelli, Nancy E Hynes, Ignacio E Schor, Sabrina A Vallone. J Mammary Gland Biol Neoplasia 2020
8

Roles of the RET Proto-oncogene in Cancer and Development.
Masahide Takahashi, Kumi Kawai, Naoya Asai. JMA J 2020
11

Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain.
Janna M Bigalke, Shintaro Aibara, Robert Roth, Göran Dahl, Euan Gordon, Sarah Dorbéus, A Amunts, Jenny Sandmark. Sci Adv 2019
18

The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
Valentina De Falco, Francesca Carlomagno, Hong-Yu Li, Massimo Santoro. Best Pract Res Clin Endocrinol Metab 2017
21

Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.
Marjan Zarif Yeganeh, Sara Sheikholeslami, Golnoush Dehbashi Behbahani, Samaneh Farashi, Mehdi Hedayati. Tumour Biol 2015
18

RET recognition of GDNF-GFRα1 ligand by a composite binding site promotes membrane-proximal self-association.
Kerry M Goodman, Svend Kjær, Fabienne Beuron, Phillip P Knowles, Agata Nawrotek, Emily M Burns, Andrew G Purkiss, Roger George, Massimo Santoro, Edward P Morris,[...]. Cell Rep 2014
41